Reducing Tobacco Use Among Women of Childbearing Age: Contributions of Tobacco Regulatory Science and Tobacco Control
Supporting Files
-
10 2020
File Language:
English
Details
-
Alternative Title:Exp Clin Psychopharmacol
-
Personal Author:
-
Description:Tobacco use has unique, adverse health consequences for reproductive-aged women, particularly should these women become pregnant. Thus, successful efforts to reduce tobacco use among this population have strong potential to improve public health and reduce health disparities. The present review examines contributions to reducing tobacco use among women of childbearing age spanning the domains of tobacco regulatory science and tobacco control from the passage of the Family Smoking Prevention and Tobacco Control Act in 2009 through September 2019. In the domain of tobacco regulatory science, such efforts include research conducted by various National Institutes of Health/Food and Drug Administration (FDA)-supported Tobacco Centers of Regulatory Science, epidemiological surveillance studies, as well as studies examining the potential impact of tobacco regulatory policies currently under consideration by the FDA (e.g., reduced nicotine content cigarettes, health warning labels). Tobacco control efforts within this same 10-year timeframe include developments in pharmacological and psychosocial approaches to promoting tobacco cessation, mHealth interventions, and tobacco control policy. Emerging issues pertinent to ongoing efforts to reduce tobacco use within the domains of both tobacco regulatory science and tobacco control are also reviewed, including e-cigarettes, comorbid health conditions, course of tobacco and other drugs of abuse, and obstacles to the dissemination and implementation of evidence-based treatment and policy. Although the past decade has seen numerous important contributions to reducing tobacco use among reproductive-aged women within both domains, existing obstacles must be surmounted to continue reducing tobacco use and protecting health among this population. (PsycInfo Database Record (c) 2020 APA, all rights reserved).
-
Subjects:
-
Keywords:
-
Source:Exp Clin Psychopharmacol. 28(5):501-516
-
Pubmed ID:31855002
-
Pubmed Central ID:PMC8168442
-
Document Type:
-
Funding:U54 DA036114/DA/NIDA NIH HHSUnited States/ ; National Institute on Drug Abuse; Tobacco Centers of Regulatory Science (TCORS)/ ; P20 GM103644/GM/NIGMS NIH HHSUnited States/ ; National Institute of Child Health and Human Development/ ; CC/CDC HHSUnited States/ ; R01 HD078332/HD/NICHD NIH HHSUnited States/ ; R01 HD075669/HD/NICHD NIH HHSUnited States/ ; National Institute of General Medical Sciences; Centers of Biomedical Research Excellence/
-
Volume:28
-
Issue:5
-
Collection(s):
-
Main Document Checksum:urn:sha-512:c9052cf1d7fa0f23df81c1d1cc183b11302f6792cb6f4823726d036954dab7d24f65f5736a1d3ad6ed16d5d234d06c15957e42de9eabbf51e0b0cf9d4b1e0922
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access